Trailing Twelve Months Revenue Growth: Biofrontera Inc. (BFRI)

Biofrontera Inc. focuses on the implementation of photodynamic therapy systems and acne treatments in the US. Looking at the annual sales growth over a 12-month period on GURU.Markets, it is evident that profit is based on the sales of BF-RhodoLED and Ameluz lamps. Growth is supported by packaging automation and software robots within the clinic. Meanwhile, the value of 29.30 serves as the baseline indicator for current dynamics.

BFRI: Biofrontera Inc. Sales Growth YoY (Last Twelve Months) 02/11/2024 - 11/15/2026

Summary analytical data breakdowns for biofrontera-us.com (BFRI)

- stock value and consensus price forecast:

Market Chart Biofrontera Inc.|BFRI - Price Target Chart

- company stock exchange capitalization indicators:

Market Value Biofrontera Inc.|BFRI - Enterprise Value

- book capitalization data:

Share Book Value Biofrontera|BFRI - Company Book Value|Market Value to Book Value biofrontera-us.com|BFRI - Aggregate Company Assets

- business debt structure and liquidity details:

- earnings and valuation multiples information:

BFRI - Net Profit|Projected Future Earnings Biofrontera Inc.|BFRI - Price to Earnings Ratio|Future Price to Earnings Multiple Biofrontera Inc|BFRI - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Biofrontera, Inc.|BFRI - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Biofrontera|BFRI - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months biofrontera-us.com|BFRI - Net earnings per share growth this year|Consensus forecast of earnings per share growth for next year Biofrontera Inc.

- sales and revenue data:

BFRI - Revenue and Sales Volume|Company Projected Revenue Biofrontera Inc|BFRI - P/S Multiple|Future Price to Revenue Biofrontera, Inc.|BFRI - Sales Growth YoY (Last Twelve Months)

Fundamental company valuation:biofrontera-us.com BFRI

Manufactured product of Biofrontera Inc.

Professional selection of resilient assets is based on an analysis of revenue growth rates, where a positive trend confirms the business's market expansion. The trailing 12-month (TTM) sales dynamics reflect the year-over-year percentage change in revenue, which for Biofrontera Inc. (BFRI) highlights the stability of consumables turnover due to the integration of pharmaceuticals into strict medical protocols.

Who Biofrontera Inc. competes with

Revenue Dynamics YoY (Last Twelve Months) KRYS|APGE - Sales Growth YoY (Last Twelve Months)|Arcutis Biotherapeutics, Inc. (ARQT) - Revenue Growth YoY (Last 12 Months)|VCEL: Sales Growth YoY (TTM)|Oruka Therapeutics (ORKA) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) sanaramedtech.com|DBVT (DBV Technologies S.A.) - Revenue Change YoY (Last 12 Months)|Sales Growth YoY (TTM) SLSN|DERM - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) FBRX (Forte Biosciences)|Revenue Growth Rate YoY (Last Twelve Months) Empro Group Inc.|SLGL: Revenue Growth YoY (Last 12 Months)|AXIL - Sales Growth YoY (TTM)|Medicus Pharma Limited (MDCX) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Sales Growth VRCA (Verrica Pharmaceuticals Inc)|HOTH (Hoth) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) vynetherapeutics.com|Sales Growth YoY (Last Twelve Months) Sonoma Pharmaceuticals Inc. (SNOA)|Revenue Growth YoY (Last 12 Months) Quoin Pharmaceuticals Ltd. QNRX|Sales Growth YoY (TTM) AZTR (Azitra Corporation)|Revenue Dynamics YoY (Last Twelve Months) DRMA|Elevai Labs Inc - Sales Growth YoY (TTM)|RVNC - Sales Growth YoY (TTM)